Drugs / PyVST
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02694783 | Mar 2016 → Dec 2019 | progressive multifocal leukoencephalopathy | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PyVST | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02694783 ↗ |
| Modality | Cell therapy | “NIH PyVST cellular product” NCT02694783 ↗ |
| Route | Intravenous | “administered by intravenous (IV) infusion” NCT02694783 ↗ |